Quantum-Si has badly missed its initial SPAC projections and is struggling to gain commercial momentum. Read why QSI stock is ...
“We believe the value of our unique portfolio of assets, including our vast biobank of more than 150,000 tumor samples, 200,000 pathology slides, and decades of longitudinal drug response ... has ...